Amgen launches new platform to help fix scientific ‘reproducibility crisis’
Drug company hopes to provide a new home for studies that try to replicate previous experimental results
Drug company hopes to provide a new home for studies that try to replicate previous experimental results
Reox given £5m boost by US biotech Reox, a company spun out of Oxford University by four professors, is believed to have struck a deal with the American biotech Amgen, providing it with £5 million...
Advocates for virtual labs finding chance to show cost and equity benefits of online experimentation
Editors have noted a “certain level of sloppiness” creeping into research papers, the executive editor of the Nature Publishing Group has said.
A biochemistry professor in the US has given £10 million to his university for a new biotechnology facility. Marvin Caruthers, who co-founded the biotechnology company Amgen, donated the money...
Model is saving research from ‘scourge of irreproducibility’, says founder Moshe Pritsker
Once upon a time the City couldn't get enough of those promising offspring of campus research - biotechnology companies. Now their stocks have taken a dive. James Norman explains why such a...